In yesterday’s Wall Street session, AMGEN Inc. (NASDAQ:AMGN) shares traded at $311.29, up 11.82% from the previous session.
AMGN stock price is now 13.39% away from the 50-day moving average and 13.69% away from the 200-day moving average. The market capitalization of the company currently stands at $166.83B.
Top 5 Artificial Intelligence Stocks to Buy for 2024
By now, you're well aware of the artificial intelligence boom. You know Big Tech has been investing billions of dollars into it.
According to Next Move Strategy Consulting, the AI market – currently valued at about $100 billion – cold grow twenty-fold by 2030 to more than $2 trillion. That means you may want to strongly consider these top AI stocks. Get our free report, "Top 5 AI Stocks to Buy in 2024."
Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In"
Sponsored
On May 03, 2024, Barclays Upgraded its previous ‘Underweight’ rating to ‘Equal Weight’ on the stock increasing its target price from $230 to quote $300, while ‘Raymond James’ rates the stock as ‘Mkt Perform’
In other news, Grygiel Nancy A., SVP & CCO sold 2,117 shares of the company’s stock on May 03 ’24. The stock was sold for $662,802 at an average price of $313.09. Upon completion of the transaction, the SVP & CCO now directly owns 9,883 shares in the company, valued at $3.08 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Dec 04 ’23, SVP & CCO Grygiel Nancy A. sold 2,096 shares of the business’s stock. A total of $572,276 was realized by selling the stock at an average price of $273.03. This leaves the insider owning 10,874 shares of the company worth $3.38 million. A total of 0.24% of the company’s stock is owned by insiders.
During the past 12 months, AMGEN Inc. has had a low of $211.71 and a high of $329.72. As of last week, the company has a debt-to-equity ratio of 12.75, a current ratio of 1.42, and a quick ratio of 0.98.
According to the Drug Manufacturers – General Company, earnings per share came in at 5, beating analysts’ expectations of 4.49 by 0.51. This compares to $3.00 EPS in the same period last year. The net profit margin was 12.82% and return on equity was 72.57% for AMGN. The company reported revenue of $8.2 billion for the quarter, compared to $6.84 billion a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 19.84 percent. For the current quarter, analysts expect AMGN to generate $8.29B in revenue.
